We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
3 Top-Ranked Healthcare Mutual Funds With Solid Upside Potential
Read MoreHide Full Article
Investors often rely on the healthcare sector to safeguard their investments. This is because the demand for healthcare services does not vary too much with respect to market conditions, and thus, the sector offers sufficient protection to the capital invested. Many pharmaceutical companies also offer regular dividends. Companies that consistently pay out dividends are financially stable and generate steady cash flows, irrespective of market conditions. Mutual funds are the perfect choice for investors looking to enter this sector since they possess the advantages of wide diversification and analytical insight.
BlackRock Health Sciences Opportunities Portfolio Investor Shares primarily invests in equity securities of health sciences companies, including healthcare equipment, providers, biotechnology and pharmaceuticals, while also investing in related international companies.
BlackRock Health Sciences Opportunities Portfolio Investor Shares has three-year annualized returns of 5.5%. As of February 2026, SHSAX held 153 issues, with 11.4% of its assets invested in Eli Lilly.
Janus Henderson Global Life Sciences invests primarily in securities of companies with a life science focus, including significant exposure to businesses within the broader life sciences sector.
Janus Henderson Global Life Sciences has three-year annualized returns of 9.9%. JNGLX has an expense ratio of 0.81%.
Fidelity Advisor Biotechnology Fund focuses on biotech-related stocks worldwide, targeting firms driving scientific and technological advances, using fundamental analysis to assess financial strength, industry position and broader market conditions, while maintaining a non-diversified portfolio.
Fidelity Advisor Biotechnology Fund has three-year annualized returns of 20.3%. Eirene Kontopoulos has been the fund manager of FBTIX since July 2018.
View the Zacks #1 Rank List
Image: Bigstock
3 Top-Ranked Healthcare Mutual Funds With Solid Upside Potential
Investors often rely on the healthcare sector to safeguard their investments. This is because the demand for healthcare services does not vary too much with respect to market conditions, and thus, the sector offers sufficient protection to the capital invested. Many pharmaceutical companies also offer regular dividends. Companies that consistently pay out dividends are financially stable and generate steady cash flows, irrespective of market conditions. Mutual funds are the perfect choice for investors looking to enter this sector since they possess the advantages of wide diversification and analytical insight.
Below, we share with you three top-ranked Healthcare mutual funds, namely BlackRock Health Sciences Opportunities Portfolio Investor Shares (SHSAX - Free Report) , Janus Henderson Global Life Sciences (JNGLX - Free Report) and Fidelity Advisor Biotechnology Fund (FBTIX - Free Report) . Each has earned a Zacks Mutual Fund Rank #1 (Strong Buy) and is expected to outperform its peers in the future. Investors can click here to see the complete list of funds.
BlackRock Health Sciences Opportunities Portfolio Investor Shares primarily invests in equity securities of health sciences companies, including healthcare equipment, providers, biotechnology and pharmaceuticals, while also investing in related international companies.
BlackRock Health Sciences Opportunities Portfolio Investor Shares has three-year annualized returns of 5.5%. As of February 2026, SHSAX held 153 issues, with 11.4% of its assets invested in Eli Lilly.
Janus Henderson Global Life Sciences invests primarily in securities of companies with a life science focus, including significant exposure to businesses within the broader life sciences sector.
Janus Henderson Global Life Sciences has three-year annualized returns of 9.9%. JNGLX has an expense ratio of 0.81%.
Fidelity Advisor Biotechnology Fund focuses on biotech-related stocks worldwide, targeting firms driving scientific and technological advances, using fundamental analysis to assess financial strength, industry position and broader market conditions, while maintaining a non-diversified portfolio.
Fidelity Advisor Biotechnology Fund has three-year annualized returns of 20.3%. Eirene Kontopoulos has been the fund manager of FBTIX since July 2018.
To view the Zacks Rank and the past performance of all Healthcare mutual funds, investors can click here to see the complete list of healthcare mutual funds.
Want key mutual fund info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing mutual funds, each week. Get it free >>